Absolute Purity Determination of a Hygroscopic Substance, Indocyanine Green, Using Quantitative NMR (qNMR)

Author:

Uchiyama Nahoko1,Hosoe Junko1,Sugimoto Naoki1,Ishizuki Kyoko1,Koide Tatsuo1,Murabayashi Mika2,Miyashita Naoto3,Kobayashi Kengo3,Fujimine Yoshinori4,Yokose Toshiyuki4,Ofuji Katsuya5,Shimizu Hitoshi5,Hasebe Takashi6,Asai Yumi6,Ena Eri6,Kikuchi Junko7,Kiyota Kohei7,Fujita Kazuhiro7,Makino Yoshinobu8,Yasobu Naoko9,Yamada Yuko10,Iwamoto Yoshiaki10,Miura Toru10,Mizui Koji10,Asakura Katsuo11,Suematsu Takako12,Kohama Ai13,Goda Yukihiro1

Affiliation:

1. National Institute of Health Sciences (NIHS)

2. Takeda Pharmaceutical Co., Ltd.

3. Daiichi Sankyo Co., Ltd.

4. Otsuka Pharmaceutical Co., Ltd.

5. Chugai Pharma Manufacturing Co., Ltd.

6. Eisai Co., Ltd.

7. SHIONOGI & Co., Ltd.

8. Juzen Chemical Corp.

9. FUJIFILM Corporation

10. FUJIFILM Wako Pure Chemical Corporation

11. JEOL Ltd.

12. JEOL RESONANCE Inc.

13. Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Reference11 articles.

1. 1) The Ministry of Health, Labour and Welfare, Japan. “The Japanese Pharmacopoeia Seventeenth Edition (2016).”: ‹https://www.mhlw.go.jp/file/06-Seisakujouhou-11120000-Iyakushokuhinkyoku/JP17_REV_1.pdf›, cited 10 March, 2020.

2. 2) The Ministry of Health, Labour and Welfare, Japan. “Supplement I to The Japanese Pharmacopoeia Seventeenth Edition (2017).”: ‹https://www.mhlw.go.jp/content/11120000/000352508.pdf›, cited 10 March, 2020.

3. 3) The Ministry of Health, Labour and Welfare, Japan. “Supplement II to The Japanese Pharmacopoeia Seventeenth Edition (2019).”: ‹https://www.mhlw.go.jp/content/11120000/000597173.pdf›, cited 10 March, 2020.

4. 4) The Ministry of Health, Labour and Welfare, Japan. “The Japanese Pharmacopoeia Seventeenth Edition (2016), General Information, Quantitative Analytical Technique Utilizing Nuclear Magnetic Resonance (NMR) Spectroscopy and its Application to Reagents in the Japanese Pharmacopoeia.”:‹https://www.pmda.go.jp/files/000217666.pdf›, cited 10 March, 2020.

5. 5) Uchiyama N., Hosoe J., Miura T., Sugimoto N., Ishizuki K., Yamada Y., Iwamoto Y., Suematsu T., Komatsu T., Maruyama T., Igarashi Y., Higano T., Shimada N., Goda Y., Yakugaku Zasshi, 140, 1063–1069 (2020).

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3